Asia-Pacific Sleep-Wake Disorder Market 2021-2027: Industry Analysis, Trends, Growth, Opportunities, and Forecast

The Asia-Pacific sleep-wake disorder market is estimated to grow at a CAGR of 6.3% during the forecast period. Countries in Asia-Pacific that are contributing to the market growth include China, India, and Japan. China is the largest contributor to the Asia-Pacific sleep-wake disorder market. The market in the region is largely driven by increasing workplace stress and the prevalence of various mental health disorders such as anxiety, depression, and others, which substantially raises the risk of sleep disorders.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-sleep-wake-disorder-market

The Asia-Pacific sleep-wake disorder market presents future opportunities for growth as the prevalence of sleep disorders such as sleep apnea and insomnia in emerging economies such as India, Australia, and China. In addition, increasing geriatric population specially in Japan is another major reason for the growing market. China is estimated to have a considerable share in the Asia-Pacific sleep-wake disorder market. Sleep insufficiency, drowsiness, and insomnia are prevalent in Chinese adolescents. Owing to the rapid industrialization and urbanization in the country; the younger adults frequently face career stress and work long hours at night, which interferes with their biological sleep rhythm and leads to insomnia.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/asia-pacific-sleep-wake-disorder-market

The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.
Some of the players operating in the Asia-Pacific sleep-wake disorder market include Koninklijke Philips N.V, Medtronic PLC, Sanofi SA, BMC Medical Co. Ltd., Takeda Pharmaceuticals Co. Ltd., Cadila Healthcare Ltd., and others. These players offer a range of products in order to deal with sleep-wake disorders. For instance, BMC Medical Co. Ltd. is one of the players headquartered in China, which comprises a robust product portfolio includes devices, masks, and diagnosis products. It offers various types of masks such as P2 Nasal Pillows Interface BMC-P2, F1B Full Face Mask, Fealite Nasal Pillows System BMC-PM, and F2 NV1 / NV2 Full Face Mask among various others.

Market Segmentation
Asia-Pacific Sleep-Wake Disorder Market by Type
• Insomnia
• Hypersomnia
• Circadian Rhythm Disorders
• Others

Asia-Pacific Sleep- Wake Disorder Market by Treatment
• Therapies
• Drugs
• Devices

Regional Analysis
• China
• Japan
• India
• Rest of Asia-Pacific

Company Profiles
• Arena Pharmaceuticals, Inc.
• BMC Medical Co., Ltd.
• Cadila Healthcare Ltd.
• Fisher& Paykel Healthcare Corp. Ltd.
• Koninklijke Philips N.V.
• Lianluo Smart Ltd.
• Medtronic PLC
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co., Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-sleep-wake-disorder-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.